David Young - Feb 9, 2023 Form 4 Insider Report for Processa Pharmaceuticals, Inc. (PCSA)

Role
President & CEO, Director, 10%+ Owner
Signature
/s/ David Young by Michael B. Kirwan, as Attorney-in-Fact
Stock symbol
PCSA
Transactions as of
Feb 9, 2023
Transactions value $
$15,000
Form type
4
Date filed
2/10/2023, 04:04 PM
Previous filing
Jan 4, 2023
Next filing
Apr 13, 2023

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction PCSA Common Stock Award $15K +18.8K +5.65% $0.80 350K Feb 9, 2023 Direct
holding PCSA Common Stock 620K Feb 9, 2023 By Young-Plaisance Revocable Trust
holding PCSA Common Stock 216K Feb 9, 2023 By Family Entities
holding PCSA Common Stock 371K Feb 9, 2023 By CorLyst, LLC
* An asterisk sign (*) next to the price indicates that the price is likely invalid.